Tempest Therapeutics, Inc.
TPST
$1.92
-$0.02-1.03%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.53% | 55.39% | 27.53% | 21.38% | -30.85% |
| Total Depreciation and Amortization | -1.52% | -1.49% | -1.47% | 38.78% | -49.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 154.84% | -75.71% | -17.02% | 3.17% | 0.06% |
| Change in Net Operating Assets | 86.75% | -80.86% | -290.98% | -46.13% | 245.01% |
| Cash from Operations | 47.28% | 19.59% | -4.92% | 20.82% | 0.32% |
| Capital Expenditure | -- | -- | -- | -- | 80.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 80.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -92.36% | 0.05% | 0.00% |
| Issuance of Common Stock | 17,715.38% | -99.64% | 141.71% | -92.67% | 438.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | 28,876.92% | -98.92% | 266.44% | -104.02% | 1,064.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.85% | 6.43% | 17.43% | -212.27% | 190.11% |